Full-Time
Store Manager
Posted on 5/9/2026
Resmed
5,001-10,000 employees
Cloud-connected medical devices and software platforms
No salary listed
Brisbane QLD, Australia
In Person
 Retail (1) |
|---|
- Previous success in retail management
- Ability to recruit and motivate a team
- Sales focused and goal-driven
- Displays excellent interpersonal, communication and mentoring skills
- A passion for creating a fantastic customer experience
- Has full knowledge of own area of responsibility and applicable practices and procedures
- Driving a culture that is laser focused on amazing customer service
- Effective leadership and management of the team
- Lead, motivate, develop & drive the team to achieve commercial targets. Demonstrate an energetic approach in both sales and management
- Liaise and build relationships with Sleep Physicians, General Physicians, Sleep laboratories and other allied health professionals to drive and maintain business
- Manage, coordinate and approve leave applications for team members. Ensure alignment with roster requirements. Manage store rosters aligned with sales volumes and team members leave. Ensure each store is running at optimal staffing levels
- Recruit, on board and mentor staff as required
- Manage stock control including but not limited to ordering, movement through stock transfers to and from the store, stock takes etc. Complete merchandising as required
- Maintain relationships of key stakeholders
- Work collaboratively with multi-function teams and other store managers
- Having the experience in managing the performance, training and development of a team is an advantage
- To really get us excited, you will be driven to learn new skills and keen to secure a role which offers exposure to an exciting industry that can offer an exciting new career
ResMed creates cloud-connected medical devices and software platforms to treat and manage sleep apnea, COPD, and other chronic diseases. Its devices (like sleep therapy gear) collect patient data and deliver therapy, while connected software platforms enable remote monitoring, coaching, and caregiver support. The company sells medical devices and offers software subscriptions, generating revenue from product sales and ongoing service fees. Unlike some competitors, ResMed combines hardware with cloud-based analytics and a broad ecosystem that supports patients, healthcare professionals, and caregivers across more than 120 countries. Its goal is to improve patient care and quality of life while reducing hospital visits and overall healthcare costs.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1989
Simplify's Take
What believers are saying
- GLP-1 therapies boost sleep apnea treatment initiation by 11% per 2.1 million patient data.
- Q3 2026 revenue hits $1.43 billion, up 11%, with gross margins expanding 290 basis points.
- Indiana distribution center opens 2027, lifting North America two-day coverage to 90%.
What critics are saying
- GLP-1 drugs reduce sleep apnea severity by 40-50%, slashing CPAP sales 15-20% within 12-24 months.
- BMC Medical captures 10% US CPAP share in 6-12 months via low-cost AirSense clones.
- CMS 2027 rule cuts DME payments 8%, compressing 62.8% gross margins starting 2027.
What makes Resmed unique
- AirSense 11 integrates AI-powered Smart Comfort setting with FDA clearance for personalized CPAP therapy.
- myAir cloud platform analyzes data from 2.1 million patients to drive GLP-1 therapy synergies.
- Nidra device acquisition expands noninvasive RLS treatments via established sleep physician channels.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
Parental Leave
401(k) Retirement Plan
Employee Assistance Program (EAP)
Company News
Robinhood Asset Management LLC purchased a new stake of 2,622 shares in ResMed Inc., valued at approximately $632,000, during the fourth quarter, according to an SEC filing. ResMed manufactures sleep apnoea and respiratory care devices, including CPAP machines, serving an industry experiencing increased demand as awareness and diagnosis of sleep disorders grows. The investment signals Robinhood Asset Management's confidence in ResMed's market position and growth potential. ResMed reported its latest quarterly earnings on 30 January 2026 and is expected to provide updated full-year financial guidance when it reports next quarterly results in late April 2026. The stake represents a strategic investment by the hedge fund in the expanding sleep apnoea treatment market.
Agentic AI fueling double-digit growth for xifin. TECH: Software Co. Rolling Out New Agents for RCM Platform March 25, 2026 SAN DIEGO - Fresh off a year of double-digit growth across multiple segments of the health care industry XiFin, Inc., is going all in on artificial intelligence agents. The revenue cycle management software company reported 16.4% operational growth in its molecular diagnostics segment and 13.3% growth across its hospital segment. According to CEO Lâle White, the company also saw significant organic growth in pharmacies and pharmaceuticals. Total user volume of XiFin's AI-enabled Empower RCM software platform rose 21.1% during the year, which White argued was a reflection of both productivity aided by the company's expanded agentic AI features and the quality of XiFin's existing data infrastructure. "The data infrastructure itself has been very instrumental in making those AI agents that we're introducing very functional and results oriented, really providing excellent results in higher reimbursement levels, faster collections and just increased revenue," White said. XiFin primarily serves medical care providers, pharmacies and insurers by connecting data like patient records, billing and pricing information, eligibility information and insurance information into one software platform. Users can then use Empower's AI and machine learning features to make their workflows more efficient and reduce the time that clerical and supervisory staff spend on administrative tasks. Most recently, the company has focused on expanding agentic AI tools specifically developed to manage tasks like appeals, document extraction, insurance matching, patient out-of-pocket estimates and complex denial prioritization. The Empower platform already reduced manual labor by around one-third for most of XiFin's clients, but White said she expects that percentage to increase with the added agentic functionalities. "What we've really created is an infrastructure that allows not only our agents to be used on it, but our clients' own agents that they may create or other vendor agents on a very significant quality database that really allows those agents to be very productive and meaningful," she said. To bolster the company's expanding AI adoption, XiFin announced its appointment in February of Sanjay Kumar as its next chief technology officer. Kumar joins XiFin after serving as CTO for the sleep health and medical device company Resmed's residential care software business. Kumar's background also includes stints with Intuit and Teradata leading cloud computing and software engineering. "Sanjay... is very well versed in AI development and AI architecture of software and how enterprise software can be leveraged to really benefit from AI, and the other way around, how AI can benefit from an enterprise software product with a very strong quality data infrastructure," White said. In addition to its organic growth, White said XiFin is actively monitoring opportunities for mergers and acquisitions if a smaller company offers a niche software product that may integrate well with the Empower platform and help XiFin grow faster in new and existing markets. Those potential acquisitions would also provide XiFin with more bandwidth to produce new products and achieve goals on the company's product roadmap, according to White. The company's growth trajectory has benefited in part from a September growth capital investment from Goldman Sachs External Investing Group, Avista Healthcare Partners and other institutional investors. Along with the funding, XiFin also added Blackstone Senior Advisor and former health care IT company Welltok CEO Jeff Margolis to its board of directors. "We think we'll be a very significant revenue cycle player in the future, and we already are in our niches, but I think we're broadening that significantly to demonstrate that it's easily transferable to other health care sectors," White said. XiFin, Inc. FOUNDED: 1999 CEO: Lâle White HEADQUARTERS: San Diego BUSINESS: Health care IT EMPLOYEES: Around 1,000 WEBSITE: xifin.com CONTACT: (858) 436-2939 NOTABLE: Lâle White was named the 2024 CEO of the Year in the large, private company category and one of the 500 most influential people in San Diego County in 2025 by the San Diego Business Journal. Eli is an award-winning reporter primarily covering the tech and life sciences industries. He previously worked as the San Diego City Hall reporter for the regional wire City News Service. He has also covered public health, transportation and state and local politics in the San Francisco Bay Area for Local News Matters, the nonprofit arm of the regional wire Bay City News Service, where he also oversaw the development and daily content management of the outlet's public health and COVID-19 news and resource webpage. He is also a contributing writer covering Minor League Baseball for the analysis and commentary website Baseball Prospectus. Eli is a graduate of San Francisco State University and a native of Northern California.
AirTouch N30i review: pros, cons & why it's a top CPAP mask in 2026. Mar 23, 2026 Finding the right CPAP mask is essential for effective therapy and a restful night's sleep. Comfort, fit, and ease of use all play a huge role in how consistent and successful CPAP therapy can be. The ResMed AirTouch N30i, the newest addition to the AirFit and AirTouch series, offers a fresh approach to nasal pillow CPAP masks. Here's a detailed look at what makes it stand out in 2026 and why it's one of its best sellers. What makes the AirTouch N30i unique? The ResMed AirTouch N30i combines the comfort of memory foam with a sleek, modern design. Unlike traditional silicone masks, the memory foam cushion adapts to the contours of your face, providing a soft, personalized fit. The mask is lightweight, less bulky than earlier AirTouch models, and designed for users who value freedom of movement and low-profile comfort. Key features. * Memory Foam Cushion: The soft, breathable cushion molds to your face, reducing pressure points and irritation while maintaining a secure seal. For those with sensitive skin or frequent leaks, the memory foam provides a noticeable comfort upgrade over silicone cushions. No more sore spots or uncomfortable pressure from traditional silicone cushions! * Top-of-the-Head Tube Design: One of the standout features of the AirTouch N30i is the top-of-the-head tubing design, which means no more tubing hanging from the front. This design supports natural movement during sleep, ideal for side sleepers and those who toss and turn. * Quiet Operation: Engineered for reduced noise, the AirTouch N30i allows for a more peaceful sleep environment for both you and your partner. * Easy Maintenance: The memory foam cushion can be wiped down for quick cleaning, and the frame is simple to wash. Note that memory foam cushions typically require replacement every 1-2 months to maintain optimal hygiene and comfort. You might be wondering how the AirTouch N30i stacks up against the AirFit N30i or the other AirTouch masks. Let's break it down. * Cushion Material: AirFit N30i uses silicone, while AirTouch N30i uses memory foam for a softer, more adaptive fit. * Fit & Comfort: Both offer top-of-the-head tubing, but the memory foam provides a gentler seal that conforms to facial features, reducing leaks and pressure points. * The AirTouch N30i is more compact, and sleeker compared to other models in the AirTouch range. It's designed to be lighter and less bulky, making it a great option for users who want the comfort of the AirTouch series with a more minimalist design. * The AirTouch N30i also features a top-of-the-head tubing system which is unique compared to other AirTouch models. This offers greater freedom of movement and reduces the possibility of mask displacement during sleep. Pros and cons of the AirTouch N30i. Like any product, the AirTouch N30i has its strengths and weaknesses. Here's a quick rundown: Pros: * Exceptional Comfort: The memory foam cushion creates a soft, personalized fit that helps reduce irritation and pressure points. * Top-of-the-Head Tube: Offers greater freedom of movement without compromising seal. * Quieter Sleep: Reduced noise for you and your partner. * Simple Maintenance: Easy to clean with a removable cushion and frame. * Versatility: Works well for both back and side sleepers. Cons: * Frequent Cushion Replacement: While the memory foam provides comfort, it does need to be replaced more frequently (every 1-2 months) than compared to silicone cushions. * Slightly Higher Price: Higher cost compared to silicone masks, though many users feel the comfort justifies it. If you decide to give the AirTouch N30i a try, here's what to expect: * A more comfortable and adaptive fit than traditional silicone masks. * Reduced mask noise for a better sleep environment. * Increased flexibility to move freely without worrying about leaks. * Simple cleaning routines, though regular cushion replacement is necessary for optimal comfort. In summary. The ResMed AirTouch N30i is a strong choice for CPAP users who prioritize comfort, freedom of movement, and a quieter sleep experience. While the memory foam cushions require regular replacement, the benefits in comfort and seal often outweigh the minor maintenance. For those struggling with leaks, discomfort, or bulkier masks, the AirTouch N30i offers a lighter, modern alternative that may transform nightly CPAP therapy. Would HelloSleep recommend it? Yes! For users seeking comfort, adaptability, and a mask that moves with them, the AirTouch N30i is worth trying. For any additional questions about the AirTouch N30i, feel free to reach out to HelloSleep at [email protected], or browse its full selection of CPAP products online at HelloSleep.ca. AirTouch N30i frequently asked questions. What makes the ResMed AirTouch N30i different from other CPAP masks? The ResMed AirTouch N30i stands out because of its memory foam cushion, which adapts to the contours of your face for a softer, more personalized fit compared to traditional silicone masks. It also features a top-of-the-head hose connection, allowing greater freedom of movement and reducing mask displacement during sleep. Is the AirTouch N30i better than the ResMed AirFit N30i? The choice between the AirTouch N30i and AirFit N30i depends on your needs. The AirTouch N30i offers enhanced comfort with its memory foam cushion, making it ideal for users with sensitive skin or frequent leaks. The AirFit N30i uses silicone cushions, which are more durable and require less frequent replacement. How often should I replace the AirTouch N30i memory foam cushion? To maintain optimal hygiene, comfort, and performance, it's recommended to replace the AirTouch N30i memory foam cushion every 1 to 2 months. Regular replacement helps ensure a proper seal and reduces the risk of irritation or buildup. Is the AirTouch N30i a good CPAP mask for side sleepers? Yes, the AirTouch N30i is an excellent CPAP mask for side sleepers and active sleepers. Its top-of-the-head tubing design keeps the hose out of the way, allowing you to change positions easily without disrupting the seal. Is the AirTouch N30i worth the price? For many CPAP users, the AirTouch N30i is worth the investment due to its superior comfort, reduced pressure points, and improved seal. While it may cost more upfront and require more frequent cushion replacements, the overall comfort and sleep quality benefits often outweigh the added cost.
Braun: Resmed to build $30 million facility in Greenwood. Posted: Feb 24, 2026 / 01:35 PM EST Updated: Feb 24, 2026 / 01:35 PM EST GREENWOOD, Ind. - Officials with the Indiana Office of Commerce and the office of Indiana Gov. Mike Braun announced on Tuesday that a new company centered on health technology will establish its first U.S. Midwest operation in Indiana. According to a news release, Resmed will invest $30 million to build out a 446,500-square-foot facility in Greenwood, which is expected to add more than 100 new, high-wage jobs to the state. The company focuses on sleep, breathing and care delivered in the home. "Indiana's life sciences sector continues to attract new global and innovative leaders to the state," Braun said in the release. "Here in the crossroads of the U.S., Resmed will be centrally located and have access to robust infrastructure, helping the company serve customers more quickly and deliver life-changing solutions." The new facility is expected to help support the distribution of products and solutions to treat sleep apnea, chronic obstructive pulmonary disease as well as other sleep and breathing disorders. The company, headquartered in San Diego, has locations in California and Georgia. The company plans to begin operations in Greenwood in 2027 with its state-of-the-art warehouse and distribution center. The release said that it will improve the company's transit coverage and shorten delivery times to Canada. The company is expected to hire for a "broad range of skills, including high-skilled technicians." The company is also expected to "invest heavily in employee training to ensure product quality and proper handling of sensitive medical equipment." "We're proud to expand our distribution network in Greenwood as part of Resmed's continued commitment to U.S. manufacturing and logistics," said Shane Azzi, the chief supply chain officer at Resmed. "Indiana's and Greenwood's strong talent base and spirit of collaboration played a major role in our decision to locate here. The new center will strengthen Resmed's ability to serve providers and patients while also supporting long-term growth in the region." The release said that the Indiana Economic Development Corporation is expected to provide Resmed up to $1.75 million in the form of incentive-based tax credits, something that officials stressed is performance-based. The city of Greenwood is also expected to offer additional incentives. "Resmed's decision to locate in Greenwood is a win for our residents and our local economy," Greenwood Mayor Mark W. Myers said in the release. "This investment reflects our pride in bringing high-quality jobs to Greenwood and expanding the region's role in delivering essential healthcare products nationwide. We're grateful that Resmed chose Greenwood as the home for this new operation."
Sleep health company plans $30M distribution center south of Indianapolis. Tuesday, February 24, 2026 01:30 PM EDT By Holly Hays, Indianapolis Business Journal GREENWOOD, Ind. - California-based health tech company Resmed plans to invest $30 million in a new distribution center in Greenwood, Gov. Mike Braun's administration announced Tuesday. The 446,500-square-foot facility at 1415 Collins Road - off of Interstate 65, between the Main Street and Worthsville Road exits - is expected to begin operating next year and will distribute products that treat sleep apnea, chronic obstructive pulmonary disease and other sleep- and breathing-related disorders, according to a press release from the Indiana Office of Commerce. The company anticipates hiring 100 employees for "high wage" positions, but Tuesday's announcement did not specify a general salary range for those jobs. The release noted the average annual salary within Indiana's life sciences sector is $148,000, citing BioCrossroads. Story Continues Below Based on Resmed's job creation plans, the Indiana Economic Development Corp. has approved $1.75 million in incentive-based tax credits. The city of Greenwood is also expected to offer incentives, but those details were also not specified in the announcement. It's the company's first facility in the Midwest, according to Braun's office, and Resmed expects it will significantly improve its two-day coverage of North America and reduce delivery times to Canada by a full day. "We're proud to expand our distribution network in Greenwood as part of Resmed's continued commitment to U.S. manufacturing and logistics," Shane Azzi, chief supply chain officer at Resmed, said in a press release distributed by IEDC. "Indiana's and Greenwood's strong talent base and spirit of collaboration played a major role in our decision to locate here. The new center will strengthen Resmed's ability to serve providers and patients while also supporting long-term growth in the region." Resmed was founded in 1989 to commercialize its positive airway pressure, or PAP, therapy mask for people with sleep apnea. It launched its first software program, aimed at helping doctors monitor patients' sleep health and better tailor their approaches, in 2003. In the years since, Resmed has specialized in cloud-connected and artificial intelligence-assisted tools to help patients across the breathing-disorder spectrum. The company recently reported revenue of $1.4 billion for the second quarter of its fiscal year, which ended Dec. 31.